Zechariah Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zechariah Wilson has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
A. Tooley
Molecular Pharmacology and Pharmacogenetics, Division of Clinical Sciences (South), The University of Sheffield, and
1 shared publication- Amin Rostami-Hodjegan
Centre for Applied Pharmacokinetic Research The University of Manchester Manchester UK
1 shared publication - Christine Beeton
Department of Integrative Physiology, Baylor College of Medicine, Houston, Texas 77030, USA
1 shared publication Gabriel Arismendi-Morillo
Biological Research Institute, Faculty of Medicine, University of Zulia, Maracaibo, Venezuela
1 shared publication- Geoffrey T. Tucker
Pharmacokinetics & Pharmacogenetics Group, University of Sheffield, UK
1 shared publication J Boyle
Molecular Pharmacology and Pharmacogenetics, Division of Clinical Sciences (South), The University of Sheffield, and
1 shared publication
Latest Publications
- 1 October 2014
- Published by Elsevier in International Immunopharmacology
- Vol. 22 (2) , 427-443
Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy
- 1 October 2014
- Published by Elsevier in International Immunopharmacology
- Vol. 22 (2) , 427-443
Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy
- Open Access
- 12 September 2003
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 56 (4) , 433-440
Inter‐individual variability in levels of human microsomal protein and hepatocellularity per gram of liver
Aims To determine levels of microsomal protein (MPPGL) and hepatocellularity (HPGL) per gram of human liver and their interindividual variability.Methods Triplicate liver samples were used to determine values of MPPGL (n = 20) and HPGL (n = 7) after accounting for the fractional loss of microsomal protein or hepatocytes during processing. Repeated measurements from each liver sample allowed the estimation of true interindividual variability in MPPGL and HPGL using ANOVA.Results The value of MPPGL ranged from 26 to 54 mg g−1 (meangeo= 33 mg g−1). The value of HPGL ranged from 65 to 185 × 106 cells g−1 (meangeo= 107 × 106 cells g−1).Conclusions There is significant interindividual variability in MPPGL, which has implications for the accurate extrapolation of in vitro data on drug metabolism to predict in vivo metabolic clearance.
- 12 September 2003
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 56 (4) , 433-440
Open AccessInter‐individual variability in levels of human microsomal protein and hepatocellularity per gram of liver
Aims To determine levels of microsomal protein (MPPGL) and hepatocellularity (HPGL) per gram of human liver and their interindividual variability.Methods Triplicate liver samples were used to determine values of MPPGL (n = 20) and HPGL (n = 7) after accounting for the fractional loss of microsomal protein or hepatocytes during processing. Repeated measurements from each liver sample allowed the estimation of true interindividual variability in MPPGL and HPGL using ANOVA.Results The value of MPPGL ranged from 26 to 54 mg g−1 (meangeo= 33 mg g−1). The value of HPGL ranged from 65 to 185 × 106 cells g−1 (meangeo= 107 × 106 cells g−1).Conclusions There is significant interindividual variability in MPPGL, which has implications for the accurate extrapolation of in vitro data on drug metabolism to predict in vivo metabolic clearance.